HPR226 Uncertainties in Regulatory Benefit-Risk Decision Making for Innovative Anticancer Therapies: Preliminary Results From a 2011-2024 Review of Extensions of Indications
Abstract
Authors
Fábio Cardoso Borges Luigi Lim Maria Manuel Teixeira Francesco Pignatti Madeline Pe Caroline Voltz Denis Lacombe Carla Torre Isabelle Huys